Labshake search
Citations for Leinco Technologies :
51 - 91 of 91 citations since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsivenessbioRxiv - Immunology 2023Quote: ... checkpoint blockade was performed by intraperitoneal injection of 200 ug anti-mouse PD-L1 (clone 10F.9G2, Leinco Technologies) or isotype control anti-rat IgG2gb ...
-
bioRxiv - Immunology 2023Quote: ... allowed to sit for 3 hours and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) for 4 hr ...
-
bioRxiv - Microbiology 2023Quote: ... Mice were injected intraperitoneally (i.p.) with 500 µg of control mAb rat IgG2a (Leinco Technologies, Inc.) or 500 µg MP1-22E9 mAb anti-GM-CSF (Leinco Technologies ...
-
bioRxiv - Genomics 2023Quote: ... and rat anti-CD11b (#C227, 1:200, Leinco Technologies, St. Louis, MO). Sequential imaging of brain samples was performed on an Olympus FluoView confocal laser-scanning microscope (FV1200 ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD10 (SJ5-1B4; 1:20; Leinco Technologies, St Louis, MO); and CD45RA (HI100 ...
-
bioRxiv - Immunology 2023Quote: ... and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) at a 40ng/ml concentration for 6 hours ...
-
bioRxiv - Immunology 2022Quote: ... ICI was given by intraperitoneal injection with 200 μg anti PD-1 (clone RMP1-14, Leinco Technologies) and 100 μg anti CTLA-4 (clone 9D9 ...
-
bioRxiv - Immunology 2022Quote: ... and 100 μg anti CTLA-4 (clone 9D9, Leinco Technologies) in volume of 200 μg 1X PBS.
-
bioRxiv - Cell Biology 2022Quote: ... Blots were washed and incubated with the secondary antibody conjugated to HRP (Leinco Technologies, M114). Blots were developed with chemiluminescent development using Immobilon ECL Ultra Western HRP substrate (Millipore ...
-
bioRxiv - Immunology 2022Quote: ... and goat anti-human PD-L1 (1:50, Leinco Technologies, B560) at 4°C overnight and washed in PBS+0.1% Tween 20 for 5 min three times ...
-
bioRxiv - Cell Biology 2022Quote: ... Goat anti-rabbit HRP secondary antibody (Leinco Technologies, R115); Goat Anti-rabbit Alexa 555 (Invitrogen ...
-
bioRxiv - Immunology 2022Quote: ... while anti-HLA-DP (Leinco Technologies) and anti-HLA-DQ (from either Biorad or MyBioSource ...
-
bioRxiv - Microbiology 2022Quote: ... they are intranasally inoculated with 10μl of 500 μg of anti-IL1RA antibodies purchased from Leinco technologies (Anti Mouse/Human IL-1ra/IL-1F3 – 500 μg) ...
-
bioRxiv - Immunology 2022Quote: ... Mice were also treated with 4 μg mIFNβ neutralising antibodies (Leinco Technologies Inc). Control groups were treated with either buffer or an IgG isotype control antibody equivalently.
-
bioRxiv - Immunology 2022Quote: ... Co-cultures were treated with 10 µg/ml of anti-Mouse IFNα and anti-Mouse IFNβ (Leinco Technologies) every 24 hours ...
-
bioRxiv - Immunology 2021Quote: ... or HLA-DP (clone B7/21, Leinco Technologies) blocking antibody were added together with the T cells57 ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant purified N-terminal domain (NTD) of the SARS-CoV-2 was obtained from Leinco Technologies Inc (Cat #S853 ...
-
bioRxiv - Neuroscience 2021Quote: ... rat anti-CD11b (#C227, Clone M1/70, 1:100, Leinco Technologies, St. Louis, MO), and rat anti-CD45 (#550539 ...
-
bioRxiv - Microbiology 2021Quote: ... Male and female mice (4-5 weeks old) were treated by intraperitoneal injection with 2 mg of an anti-mouse IFNAR1 blocking antibody (MAR1-5A3, from Leinco Technologies). The next day ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Fc Block (CD32/CD16) (Leinco Technologies; St. Louis, MO), counting beads (Spherotech ...
-
bioRxiv - Immunology 2021Quote: ... inoculum was replaced with CM1 containing 50 µM ACV and an anti-mouse IFNAR-1 antibody (Leinco Tech I-1188, 1:1000) for 5-6 days ...
-
bioRxiv - Cell Biology 2021Quote: ... or by Leinco Technologies, Inc ...
-
bioRxiv - Immunology 2021Quote: ... mice were administered by IP injection either PBS vehicle or αPD-L1 (Leinco Technologies, Inc. Clone 10F.9G2) at a dose of 200 µg/mouse in a volume of 100µL ...
-
ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signalingbioRxiv - Microbiology 2021Quote: ... that for detection of interferon alpha and beta receptor 1 (IFNAR-1) was purchased from Leinco Technologies, Inc ...
-
bioRxiv - Immunology 2021Quote: ... CD16 (Clone 3G8, Leinco Technologies, Fenton, MO), and CD45 (Clone HI30 ...
-
bioRxiv - Immunology 2021Quote: Anti-human CD11b (Clone M1/70, Leinco Technologies, Fenton, MO) was conjugated with Alexa Fluor 532 NHS ester according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2021Quote: ... Mouse anti-mouse IFNAR1 (MAR1-5A3) and isotype control (GIR208, mouse anti-human IFNGR-α chain) were purchased from Leinco Technologies Inc ...
-
bioRxiv - Cancer Biology 2020Quote: ... (clone RA3-6B2 Rat IgG2a, Leinco technologies, Inc) were injected individually and in combination into the peritoneal cavity of the mice ...
-
bioRxiv - Immunology 2020Quote: ... mice were treated with 2 mg of an Ifnar1-blocking antibody (MAR1-5A3, Leinco Technologies) by i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... Tumor bearing C57BL/6J mice were treated with either 100 μg/mouse isotype control antibody (Leinco Technologies, R1367) or with 100 μg/mouse anti-mouse-Pd-1 (Leinco Technologies ...
-
bioRxiv - Cancer Biology 2020Quote: ... or with 100 μg/mouse anti-mouse-Pd-1 (Leinco Technologies, P372) one and six days post tumor injection ...
-
bioRxiv - Immunology 2020Quote: ... plus 500 μg of neutralizing antibody against IFN-γ (Leinco Technologies, Inc., I-1190) (n = 13 ...
-
bioRxiv - Immunology 2020Quote: ... or 500 μg of neutralizing antibody against TNF-α (Leinco Technologies, Inc., T-703) plus 500 μg of neutralizing antibody against IFN-γ (Leinco Technologies ...
-
bioRxiv - Immunology 2020Quote: ... Infected mice were administered intraperitoneally 200 μl of DPBS containing 500 μg of isotype control (Leinco Technologies, Inc., I-536) (n = 12 ...
-
bioRxiv - Immunology 2020Quote: ... plus 500 μg of neutralizing antibody against IFN-γ (Leinco Technologies, Inc., I-1190) (n = 14 ...
-
bioRxiv - Immunology 2020Quote: ... or 500 μg of neutralizing antibody against TNF-α (Leinco Technologies, Inc., T-703) plus 500 μg of neutralizing antibody against IFN-γ (Leinco Technologies ...
-
bioRxiv - Immunology 2020Quote: ... age- and gender-matched 6-to 8-week-old WT mice were administered intraperitoneally 200 μl of DPBS containing 500 μg of isotype control (Leinco Technologies, Inc., I-536) (n = 10 ...
-
bioRxiv - Immunology 2020Quote: ... cells were incubated with an anti-IFNAR1 antibody or a mouse IgG1 isotype control (Leinco Technologies) for 20 minutes at 37°C ...
-
bioRxiv - Immunology 2020Quote: ... injected once with 1mg of anti-IFNAR1 (clone MAR1-5A3) or mouse IgG1 isotype control (clone HKSP) (Leinco Technologies) on either the day of inoculation (“early” ...
-
bioRxiv - Immunology 2020Quote: ... mice were intraperitoneally (i.p.) injected once with 500μg of anti-Ly6G (clone 1A8) or rat IgG2a isotype control (anti-trinitrophenol+KLH) (Leinco Technologies) diluted in sterile phosphate buffered saline (PBS ...
-
bioRxiv - Microbiology 2020Quote: ... Mice were rendered susceptible to ZIKV infection via intraperitoneal (i.p.) injection of 2mg of α-IFNAR1 antibody (Mar1-5A3; Leinco Technologies) [20 ...